Study guide

2.1 Radioactive Materials, Isotopes, and Decay Modes

Certified Nuclear Medicine Technologist CNMT

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current CNMT Exam Facts 1.2 How to Use This Guide

2 Radiation Physics Fundamentals

2.1 Radioactive Materials, Isotopes, and Decay Modes 2.2 Decay Calculations and Counting Statistics 2.3 Interactions of Radiation with Matter 2.4 Radiation Detector Types and Principles

3 Biological Effects & ALARA

3.1 Biological Effects of Radiation Exposure 3.2 ALARA and Protection Calculations 3.3 Dose Limits, Surveys, and Personal Monitoring

4 NRC & Regulatory Compliance

4.1 NRC Areas, Spills, Waste, and Records 4.2 Written Directives and DOT Shipping 4.3 EPA, OSHA, HIPAA, FDA, and USP Standards 4.4 Radioactive Waste Disposal and Regulatory Records

5 Generators & Kit Preparation

5.1 Radionuclide Generators and Quality Control 5.2 Radiopharmaceutical Kit Preparation 5.3 Radiopharmaceutical Quality Control

6 Tc-99m Diagnostic Agents

6.1 Tc-99m Cardiac Imaging Agents 6.2 Tc-99m Bone, Renal, and GU Agents 6.3 Tc-99m GI and Hepatobiliary Agents 6.4 Tc-99m CNS, Infection, and Labeled Cells

7 Non-Tc Diagnostic & PET Agents

7.1 Iodine and Indium Diagnostic Agents 7.2 Gallium, Thallium, Xenon, and Miscellaneous Agents 7.3 PET Radiopharmaceuticals 7.4 Neurologic, Breast, and Neuroendocrine PET Agents

8 Therapeutics, Adjuncts & Administration

8.1 Therapeutic Radiopharmaceuticals 8.2 Interventional and Adjunct Pharmaceuticals 8.3 Blood Labeling and Administration Techniques 8.4 Blockade, Comfort, and Gastrointestinal Adjunct Agents

9 Non-Imaging Instrumentation

9.1 Well Counters, Probes, and Survey Meters 9.2 Dose Calibrator Quality Control 9.3 Auxiliary and Patient Care Equipment

10 Imaging Systems & Quality Control

10.1 Gamma Camera Quality Control 10.2 SPECT and SPECT/CT Systems 10.3 PET and PET/CT Systems and QC 10.4 CT Systems, PACS, and Information Systems 10.5 CT Radiation Dose, Safety Alerts, and Protocol Optimization

11 Pulmonary, Bone, Oncology & Infection Imaging

11.1 Pulmonary Imaging Procedures 11.2 Bone and Musculoskeletal Imaging 11.3 Oncology Imaging Procedures 11.4 Infection Imaging Procedures

12 Renal, Endocrine & Hematopoietic Imaging

12.1 Renal and Genitourinary Imaging 12.2 Endocrine Imaging (Thyroid, Parathyroid, Adrenal) 12.3 Hematopoietic and Bone Marrow Imaging 12.4 Thyroid Uptake Measurement and Radioiodine Survey Technique

13 Cardiovascular Procedures

13.1 Myocardial Perfusion Imaging 13.2 Cardiac Function, Viability, and Special Studies 13.3 Exercise and Pharmacologic Stress Testing

14 GI, CNS, Therapy & Hybrid CT Procedures

14.1 Gastrointestinal Procedures 14.2 Central Nervous System Procedures 14.3 Radionuclide Therapy Procedures 14.4 CT and Hybrid Imaging in Nuclear Medicine 14.5 CSF Studies: Cisternography, Leak Localization, and Shunt Patency

15 Patient Care & Clinical Workflow

15.1 Patient Care, Education, and Consent 15.2 Scheduling and Radiopharmaceutical Procurement 15.3 Acquisition, Positioning, and Image Quality 15.4 Image Processing and Quantitative Analysis 15.5 Non-Imaging Studies: Specimens, Counting, and Error Analysis

2.1 Radioactive Materials, Isotopes, and Decay Modes

Key Takeaways Explain This Topic AI

An isotope has the same atomic number (Z) but a different mass number (A); a nuclide is a specific nuclear species defined by Z and A

Tc-99m decays by isomeric transition, emitting a 140 keV gamma photon with a physical half-life of about 6.02 hours

F-18 is a positron (β+) emitter used in PET; I-131 emits β− and high-energy gammas; Ra-223 is an α emitter used for bone metastases

Activity units: 1 Ci = 3.7 × 10¹⁰ Bq; 1 mCi = 37 MBq — clinic doses are usually expressed in mCi or MBq

Metastable states (the “m” in Tc-99m) are excited nuclear levels that last long enough (seconds to hours) to be clinically useful before decaying by IT/gamma emission

Last updated: August 2026

Radioactive Materials, Isotopes, and Decay Modes

Quick Answer: Nuclides used in nuclear medicine are unstable nuclei that transform by α, β−, β+, electron capture, isomeric transition, or gamma emission. Know each mode’s product and the exam’s flagship examples: Tc-99m (IT/140 keV γ, T½ ≈ 6.02 h), F-18 (β+/PET, T½ ≈ 110 min), I-131 (β− + γ, therapy/imaging), and Ra-223 (α, bone therapy). Convert activity with 1 mCi = 37 MBq and 1 Ci = 3.7 × 10¹⁰ Bq .

Atoms, Nuclides, and Isotopes

An atom is defined by its atomic number (Z) — the number of protons — and its mass number (A) — protons plus neutrons. A nuclide is a specific nuclear species with a given Z and A (for example, ⁹⁹ᵐTc or ¹⁸F). Isotopes of an element share the same Z but differ in neutron number (and therefore A). Technetium has many isotopes; only a few (notably Tc-99m and Tc-99) matter in nuclear medicine technology (NMT).

Stable nuclides do not change spontaneously. Radioactive nuclides (radionuclides) transform until they reach a more stable configuration. That spontaneous transformation is radioactive decay , and the rate is a nuclear property independent of chemical form, temperature, or pressure under ordinary clinical conditions. The daughter may itself be radioactive (decay chain) or stable.

Half-Life and Decay Energy

Physical half-life (T½) is the time required for activity to fall to half its initial value. Half-lives range from seconds (e.g., Rb-82 ≈ 75 s) to days (I-131 ≈ 8.0 d) to years (Co-57 ≈ 272 d for camera QC sources). On the CNMT exam and in the clinic you memorize the workhorses:

  • Radionuclide Approx. T½ Principal radiation Typical use
  • Tc-99m 6.02 h 140 keV γ (IT) Most SPECT/planar diagnostics
  • F-18 ~110 min β+ (511 keV annihilation) PET (FDG and others)
  • I-131 8.0 d β− + 364 keV γ Thyroid therapy; residual imaging
  • I-123 13.2 h 159 keV γ Thyroid imaging
  • In-111 2.8 d 171 & 245 keV γ Octreotide, WBC labeling
  • Ga-67 3.3 d Multiple γ (93–300 keV range) Infection/inflammation (historical)
  • Tl-201 73 h Hg x-rays ~69–80 keV; γ Myocardial perfusion (less common now)
  • Ra-223 11.4 d α (chain) Castrate-resistant prostate bone mets
  • Xe-133 5.2 d 81 keV γ Ventilation

Decay energy is the energy released per transformation (keV or MeV). Photon energy determines collimator choice, window settings, and penetration. Particle energy determines range in tissue and therapeutic effect. You do not need to memorize every MeV value, but you must link mode → product radiation for the common agents.

Modes of Decay

1. Alpha (α) decay. The nucleus ejects a helium nucleus (2 protons + 2 neutrons). α particles are heavy, highly ionizing, and travel only tens of micrometers in tissue — excellent for therapy when localized, poor for external imaging. Ra-223 dichloride (Xofigo) is the classic NMT α therapy example; its daughters also emit radiation, so radiation-safety handling differs from pure γ emitters.

2. Beta-minus (β−, negatron) decay. A neutron converts to a proton; an electron and antineutrino are emitted. Z increases by 1. Continuous energy spectrum up to E_max. I-131 is the primary β− therapeutic example; its accompanying γ allows post-therapy imaging and requires shielding and distance rules different from pure β emitters.

3. Beta-plus (β+, positron) decay. A proton converts to a neutron; a positron and neutrino are emitted. Z decreases by 1. The positron annihilates with an electron, producing two 511 keV photons ~180° apart — the basis of PET coincidence imaging. F-18 is the flagship PET radionuclide; others include C-11, N-13, O-15, Ga-68, and Rb-82.

4. Electron capture (EC). An orbital electron is captured by the nucleus; a proton becomes a neutron. Z decreases by 1. Characteristic x-rays and Auger electrons follow. Many NMT nuclides mix EC with other modes (e.g., I-123 primarily EC/γ; Tl-201 primarily EC).

5. Isomeric transition (IT) and gamma emission. An excited nucleus drops to a lower energy state by emitting a γ photon (or by internal conversion). When the excited state is long-lived enough to be treated as a separate species, it is metastable — marked with m , as in Tc-99m . Tc-99m → Tc-99 by IT, emitting primarily a 140 keV photon (high internal-conversion fraction also produces conversion electrons and characteristic x-rays). Metastable generators (Mo-99 → Tc-99m) exploit this.

6. Internal conversion. Instead of emitting a γ, the nucleus transfers energy to an orbital electron that is ejected. Important for dosimetry and for understanding that “γ emitters” still produce local electron dose.

Activity Units

Activity (A) is the number of decays per unit time.

  • Unit Definition / conversion
  • Becquerel (Bq) 1 disintegration per second (SI unit)
  • Curie (Ci) 3.7 × 10¹⁰ Bq
  • millicurie (mCi) 1 × 10⁻³ Ci = 37 MBq
  • megabecquerel (MBq) 1 × 10⁶ Bq

Clinic shorthand: a typical adult FDG dose might be ~10 mCi ≈ 370 MBq; a bone scan dose might be ~20–25 mCi Tc-99m MDP. Always convert carefully when reading European literature (MBq) versus U.S. labels (mCi).

Why Mode Matters Clinically

Imaging modality: γ → Anger camera/SPECT; β+ → PET; α → therapy only (no diagnostic image from α itself).

Shielding: high-energy γ (I-131 364 keV, PET 511 keV) needs thicker lead/tungsten than Tc-99m 140 keV; β needs low-Z (plastic) first to limit Bremsstrahlung, then lead as needed.

Biological effect: α and β deposit energy locally (therapy); γ deposits energy over longer paths and is better for external detection.

Master the table of workhorse nuclides, the six decay modes, and unit conversions — Domain I repeatedly tests exactly these links.